Long-term exposure to low frequency noise (LFN) below 500 Hz has attracted considerable scientific scrutiny. Thickened heart tissue, depressions, irritability aggression and isolation are typical symptoms of this whole-body pathology referred to as vibroacoustic syndrome.
This case study explores vibroacoustic lung therapy’s successful management of COVID-19 viral pneumonia using vibroacoustic therapy in an individual with COVID-19 virus infection. Positive trends were evaluated using various indicators such as blood gas composition and oxygen saturation levels to gauge progress of treatment.
Pathophysiology
Vibroacoustic disease is a systemic pathology caused by prolonged exposure to low frequency noise (LFN). This disease affects all areas of the body, from lungs, heart and joints to professional pilots and cabin crew, ship machinists, restaurant workers and disk-jockeys; as well as populations exposed to environmental LFN sources. Vibroacoustic symptoms range from generalised discomfort through symptoms to multi-organ failure and, potentially, even death in extreme cases.
First recognized in 1987 during an autopsy of a VAD patient’s body after their death, thickening of blood vessels and organs including heart valves, pericardium and lungs were observed – this revelation sent shockwaves through medical circles who believed LFN-related pathologies to be restricted only to nervous and respiratory systems.
Since that time, numerous studies have been published describing the pathophysiology and symptoms of this syndrome, some in conjunction with clinical trials. At present, one of the most notable trials has taken place at City Infectious Diseases Hospital of Astana in Republic of Kazakhstan where a pilot study on 60 patients suffering from pneumonia caused by coronavirus infection was carried out. All patients were on mechanical ventilators and divided into two groups for vibroacoustic pulmonary therapy on the “VibroLung” device; one group underwent acute respiratory distress syndrome therapy while the other received pneumonia treatment on “Pneumona.” Both groups showed positive results from therapy with increases in oxygen content and decreases in carbon dioxide level in arterial blood.
Chondromalacia, an articular condition which impairs knee joint motion quality, was successfully treated using this kind of therapy. Chondromalacia produces abnormal vibroacoustic signals with increasing signal amplitudes as the cartilage degraded, from superficial layer cartilage degradation through subchondral bone destruction.
Symptoms
Vibroacoustic therapy is an advanced sound treatment which utilizes pure low frequency sine wave vibrations delivered via an apparatus with connected speakers to deliver pure low frequency sine waves to the body for pain relief, improving circulation and increasing movability for patients. (7) This technique has become popular worldwide.
Monitoring Vibroacoustic Disease was released late 2002 by four doctors. They determined that LFN exposure caused mood changes and aggressiveness; an extracellular matrix change (thickening blood vessels); abnormal cardiovascular structures including the development of pulmonary fibrosis that has been replicated under laboratory conditions; as well as lung tumors which had also been replicated within lab settings.
Studies suggest that LFN noise causes stress by stimulating similar hormones to those released in response to physical threats like car accidents and fights between individuals. These hormones have been shown to lead to physical problems including back and neck pain; sinus infections; headaches; as well as gastrointestinal issues like ulcers or diarrhea.
Noise generated by LFN noise can interfere with the normal functioning of both inner ears and eyes, leading to balance disturbances as well as seizure-related or epileptic seizures. These disruptions may contribute to epilepsy symptoms or seizures.
Researchers are alarmed that vibrations linked to vibroacoustic syndrome could also be responsible for an upsurge in noise and vibration complaints from residents living near industrial wind turbines. Wind farms produce vibrations which experts believe can be felt as well as heard; experts suspect these may cause headaches, insomnia, rashes and other symptoms experienced by those who live nearby wind farms – similar to what was described by earlier studies of vibration-induced health effects caused by dance clubs, powerful car audio systems and twin-turboprop aircrafts.
Diagnosis
Low frequency noise (LFN, 500Hz and below including infrasound) exposure has long been documented to induce respiratory pathology. While initially this was not considered an effect of LFN exposure, today it can be viewed as one of several contributing factors to vibroacoustic disease.
VAD, or Vascular Artery Disease, is a whole-body pathology characterized by abnormal proliferation of extracellular matrix molecules that has been reported among various populations exposed to LFN radiation. Cases have been observed among aircraft technicians, commercial and military pilots/cabin crewmembers/ship machinists/restaurant workers/disk jockeys as well as restaurant workers/restaurant workers (among others).
Reactive Arthritis (RA) is a progressive, multi-stage disease characterized by an accumulation of lesions to various areas of the body – cardiovascular, cardiac, musculoskeletal and cognitive. Some lesions may be specific to this syndrome such as changes to pericardial and thoracic membranes; other findings, like changes to extracellular matrix blood vessels, are more frequently seen with different forms of stress-induced pathology.
The severity of VAD symptoms varies with its duration and intensity of exposure, although initial signs often include chest pain, fatigue, backache, gastrointestinal upset, fungal/viral infections, skin disorders, respiratory complications as well as respiratory complications. More serious symptoms may include irritability, mood swings depression rage attacks; potentially even suicide attempts in extreme situations.
An echocardiogram should be conducted annually on LFN-exposed workers to detect early signs of VAD and remove them before irreparable damage has taken place. This strategy can save both money and prevent more severe complications, such as cardiovascular events or even pulmonary fibrosis which has been replicated experimentally animal models.
An alternative approach must be taken towards noise in order to combat VAD at work. Portugal’s national disability tables cover nearly all symptoms, yet do not identify LPALF noise as a risk, thus leaving out its most grave consequences such as suicide. A significant effort must be undertaken in implementing a screening program for LPALF noise and vibration-induced toxicity among employees.
Treatment
Vibroacoustic Syndrome is a whole-body pathology caused by long-term exposure to low frequency noise (LFN). LFN is a form of mechanical vibration and an environmental contaminant; prolonged LFN exposure has been linked with various pathologies including abnormal proliferation of extra-cellular matrix and biotensegrity structures that cause structural changes within tissues, organs and cells.
Damage from fibroacoustic syndrome can result in an array of symptoms, from depression and chronic pain to increased susceptibility to infections and an increase in susceptibility. Severity varies with each case of fibroacoustic syndrome and treatment options include psychotherapy, medication and holistic services like vibroacoustic therapy.
Vibration sound therapy has been shown to relieve both pain and stress for children and adults, while improving cognitive functions in people living with ADHD or autism. Furthermore, vibration sound therapy can also be used effectively in managing chronic conditions like fibromyalgia or arthritis pain relief.
Vibration sound therapy (VAT) may become more widely recognized as an effective means of pain management as studies continue, yet it must be remembered that VAT should only be used alongside other treatments; not as a replacement. Furthermore, VAT should never be administered to anyone with pacemakers or similar implanted medical devices.
Fibroacoustic lung therapy, a form of physical therapy which uses vibroacoustic devices to stimulate lung tissue, has proven highly successful for treating coronavirus infections and respiratory ailments like pneumonia or bronchitis. One patient suffering from periprosthetic sepsis and COVID-19 experienced dramatic improvement after receiving vibroacoustic pulmonary therapy treatments every 3 hours. Vibroacoustic therapy helps strengthen immunity while improving oxygenation. Increased movement of pulmonary surfactant improves gas exchange in the lungs. Furthermore, this treatment helps avoid complications and shorten hospital stays; after initiating it bronchial inflammation and airway resistance both significantly decreased; in fact on day eight the patient was out of intensive care unit!
